JAK2 and acquired polycythemia vera: More than 95% of patients with PV present with disease‐defining mutations such as JAK2 V617F and JAK2 exon 12,2 and the presence of these mutations has been adopted as a major criterion in the diagnostic criteria for PV by the World Health Organization.3